Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.85
Delayed Data
As of Sep 01
 -0.33 / -5.34%
Today’s Change
5.25
Today|||52-Week Range
18.42
-58.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash35.3M0.0025.8M74.3M
 
 
 
 
Short Term Investment Cash6.8M-20.6M41.0M18.6M
 
 
 
 
 
Cash & Short Term Investments39.5M14.7M55.7M85.8M
 
 
 
 
 
 
ReceivablesReceivables7.0K0.00--882.0K
 
 
 
 
InventoriesInventories0.00----7.8M
 
 
 
Current AssetsOther Current Assets534.0K430.0K1.2M4.1M
 
 
 
 
 
Current Assets40.0M15.1M56.9M98.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross855.0K879.0K1.2M2.7M
 
 
 
 
 
Depreciation-788.0K-823.0K-877.0K-1.2M
 
 
 
 
 
Intangible Assets3.2M3.2M3.2M3.2M
 
 
 
 
 
Other Assets3.4M3.4M3.5M3.5M
 
 
 
 
 
Total Assets43.5M18.6M60.8M103.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable8.9M7.2M14.0M24.1M
 
 
 
 
 
Other Current Liabilities0.000.000.00414.0K
 
 
Other Liabilities9.8M8.0M15.3M29.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt2.6M0.000.000.00
 
 
Deferred Taxes0.000.000.00-700.0K
 
 
Other Liabilities35.0K36.0K38.0K133.0K
 
 
 
 
 
Total Liabilities12.4M8.1M15.4M30.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity31.0M10.5M45.4M73.5M
 
 
 
 
 
Total Shareholder Equity31.0M10.5M45.4M73.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding71.0M71.9M82.6M92.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.